five

Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

收藏
DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00001235/isLanding
下载链接
链接失效反馈
官方服务:
资源简介:
The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' HZ/su vaccine in subjects' ≥ 50 years of age (YOA) who previously have had Herpes Zoster (HZ). The data collected will be compared with the data from subjects without HZ in other HZ/su trials.
提供机构:
Vivli
创建时间:
2018-10-27
二维码
社区交流群
二维码
科研交流群
商业服务